IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AUPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Monday for Aurinia Pharmaceuticals Inc
(Updated on Apr 15, 2024)

Hold candidate since Apr 12, 2024 Loss -1.18% PDF

The Aurinia Pharmaceuticals Inc stock price fell by -1.18% on the last day (Monday, 15th Apr 2024) from $5.10 to $5.04. During the last trading day the stock fluctuated 4.10% from a day low at $5.02 to a day high of $5.23. The price has fallen in 6 of the last 10 days and is down by -6.67% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -314 thousand shares and in total, 1 million shares were bought and sold for approximately $6.75 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.61% during the next 3 months and, with a 90% probability hold a price between $2.45 and $3.35 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Check out how to make money doing surveys! Ad

AUPH Signals & Forecast

There are mixed signals in the stock today. The Aurinia Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.05 and $5.27. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 2.23%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Aurinia Pharmaceuticals Inc stock

Aurinia Pharmaceuticals Inc finds support from accumulated volume at $5.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.206 (4.10%) between high and low. For the last week, the stock has had daily average volatility of 3.52%.

Our recommended stop-loss: $4.76 (-5.65%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (AUPH) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Aurinia Pharmaceuticals Inc to open at $5.10, and during the day (based on 14 day Average True Range), to move between $4.83 and $5.25, which gives a possible trading interval of +/-$0.210 (+/-4.17%) up or down from last closing price. If Aurinia Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 8.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.01 (0.60%) than the resistance at $5.85 (16.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aurinia Pharmaceuticals Inc stock A Buy?

Aurinia Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.410 Hold/Accumulate Unchanged

Predicted Opening Price for Aurinia Pharmaceuticals Inc of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$5.10 ( 1.10%) $5.04

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AUPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.30 5.19 %
R2 5.22 3.62 %
R1 5.17 2.66 %
Current price: 5.04
Support S1 5.02 -0.463 %
S2 4.97 -1.43 %
S3 4.89 -2.99 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.02 19.44 %
R2 6.00 19.05 %
R1 5.85 16.07 %
Current price 5.04
Support S1 5.01 -0.595%
S2 4.99 -0.99%
S3 4.97 -1.39%

FAQ

What is the symbol for Aurinia Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Aurinia Pharmaceuticals Inc is AUPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aurinia Pharmaceuticals Inc Stock?
Aurinia Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Aurinia Pharmaceuticals Inc Stock?
Aurinia Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aurinia Pharmaceuticals Inc Stock.

What's the current price of Aurinia Pharmaceuticals Inc Stock?
As of the end of day on the 2024-04-15, the price of an Aurinia Pharmaceuticals Inc (AUPH) share was $5.04.

What is the 52-week high and low for Aurinia Pharmaceuticals Inc Stock?
The 52-week high for Aurinia Pharmaceuticals Inc Stock is $12.42 and the 52-week low is $4.85.

What is the market capitalization of Aurinia Pharmaceuticals Inc Stock?
As of the 2024-04-15, the market capitalization of Aurinia Pharmaceuticals Inc is 728.875M.

When is the next earnings date for Aurinia Pharmaceuticals Inc?
The upcoming earnings date for Aurinia Pharmaceuticals Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT